BIIB019
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIIB019, covering 2019-12-04 to 2019-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 [Phase 3]